Sentien Biotechnologies, Inc.

MEDFORD, MA · CIK 0001650699 · Medtech · Private

Extracorporeal bioreactor system that delivers mesenchymal stem cell secretions to treat acute myocardial infarction

Grants
$4.6M
5 awards
Sector median: 1
Raised
$1.0M
1 Form D · Aug 2015
134 months since last filing
Contracts
$610K
2 awards · Defense, Health and Human S
#368 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · SBIR Phase I Army 2011.2 Log #11256002$99,974
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Stem Cell Bioreactor for Cardiac Care$240,729
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive$1,006,437
Private capital raisedForm D · SEC$1,049,999
Federal grantDepartment of Health and Human Services · Phase II · Stem Cell Bioreactor for Cardiac Care$1,571,857
Federal grantDepartment of Health and Human Services · Phase II · Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive$962,626
Federal grantDepartment of Health and Human Services · Phase II · Stem Cell Bioreactor for Cardiac Care$800,030
Federal contractDepartment of Health and Human Services · Sentien Biotechnologies, Inc.: R&d Of Ex Vivo Cell Therapy$510,265
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
365Starr Life Sciences Corp.$642K$4.1M
366Beacon Biosignals$641K$133M
367Medigus$623K$8.6M
368Sentien Biotechnologies, Inc.$610K$1.0M
369PGXL TECHNOLOGIES LLC$606K—
370Ribomed Biotechnologies, Inc.$603K—
371SONATA SCIENTIFIC LLC$600K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Greg BaileyDirector
  • Rich GanzDirector
  • Martin HeideckerDirector
  • Brian MillerDirector · Executive Officer
  • Biju ParekkadanDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.